Literature DB >> 9015405

Low-dose inotropic stimulation during left ventricular ischaemia does not worsen post-ischaemic dysfunction.

G G Schwartz1, Y Xu, C Greyson, J Cohen, L Lu.   

Abstract

OBJECTIVE: Inotropic agents are used clinically to improve ventricular function during ischaemia. The goal of this study was to determine whether inotropic stimulation during moderate left ventricular (LV) ischaemia exacerbated post-ischaemic LV dysfunction.
METHODS: In 18 open-chest, anesthetized pigs, LV pressure versus subendocardial segment length loops were used to generate regional preload-recruitable stroke work (PRSW) and LV end-diastolic pressure (EDP) versus end-diastolic segment length (EDL) relations. Ischaemia was produced by constant, partial constriction of the mid anterior descending coronary artery for 90 min. Nine pigs received dobutamine (4 micrograms.kg-1.min-1, i.v.) during the final 60 min of ischaemia (Group 2), while 9 other pigs did not (Group 1).
RESULTS: During unstimulated ischaemia, anterior subendocardial blood flow (Group 1, 0.27 +/- .05; Group 2, 0.30 +/- .07 ml.g-1.min.-1, mean +/- s.e.m.) and steady-state PRSW (Group 1, 30 +/- 4%; Group 2, 27 +/- 5% of baseline) were similar in both groups. Dobutamine stimulation during ischaemia increased heart rate, mean arterial pressure, subendocardial blood flow, oxygen consumption and steady-state PRSW of the ischaemia zone, but not lactate release. After 60 min reperfusion, steady-state ischaemic zone PRSW remained markedly and nearly equally reduced in both groups (Group 1, 28 +/- 4%; Group 2, 23 +/- 5% of baseline). Reduced PRSW after reperfusion was due primarily to persistent rightward shift of the PRSW intercept with only a modest contribution from reduced PRSW slope.
CONCLUSIONS: Low-dose inotropic stimulation during moderate regional LV ischaemia increases aerobic, but not anaerobic energy metabolism, and does not worsen post-ischaemic dysfunction.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9015405     DOI: 10.1016/s0008-6363(96)00150-2

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  7 in total

1.  Glucose-insulin-potassium preserves systolic and diastolic function in ischemia and reperfusion in pigs.

Authors:  P Zhu; L Lu; Y Xu; C Greyson; G G Schwartz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-02       Impact factor: 4.733

2.  Metformin prevents ischaemic ventricular fibrillation in metabolically normal pigs.

Authors:  Li Lu; Shuyu Ye; Rebecca L Scalzo; Jane E B Reusch; Clifford R Greyson; Gregory G Schwartz
Journal:  Diabetologia       Date:  2017-05-11       Impact factor: 10.122

3.  The PPAR-alpha activator fenofibrate fails to provide myocardial protection in ischemia and reperfusion in pigs.

Authors:  Ya Xu; Li Lu; Clifford Greyson; Mona Rizeq; Karin Nunley; Beata Wyatt; Michael R Bristow; Carlin S Long; Gregory G Schwartz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-12-09       Impact factor: 4.733

4.  Troglitazone improves recovery of left ventricular function after regional ischemia in pigs.

Authors:  P Zhu; L Lu; Y Xu; G G Schwartz
Journal:  Circulation       Date:  2000-03-14       Impact factor: 29.690

5.  PPAR-gamma activation fails to provide myocardial protection in ischemia and reperfusion in pigs.

Authors:  Ya Xu; Michael Gen; Li Lu; Jennifer Fox; Sara O Weiss; R Dale Brown; Daniel Perlov; Hasan Ahmad; Peili Zhu; Clifford Greyson; Carlin S Long; Gregory G Schwartz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-11-04       Impact factor: 4.733

6.  Deleterious effects of acute treatment with a peroxisome proliferator-activated receptor-gamma activator in myocardial ischemia and reperfusion in pigs.

Authors:  Ya Xu; Li Lu; Clifford Greyson; Jenny Lee; Michael Gen; Koichiro Kinugawa; Carlin S Long; Gregory G Schwartz
Journal:  Diabetes       Date:  2003-05       Impact factor: 9.461

7.  Impaired contractile recovery after low-flow myocardial ischemia in a porcine model of metabolic syndrome.

Authors:  Janice V Huang; Li Lu; Shuyu Ye; Bryan C Bergman; Genevieve C Sparagna; Mohammad Sarraf; Jane E B Reusch; Clifford R Greyson; Gregory G Schwartz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-01-18       Impact factor: 4.733

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.